MOR-107

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMOR-107

Drug Alias NameLP 2lantipeptideslanthionine-peptidesLP-2LP-2-3 +[6]

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionAngiotensin II receptor type 2 agonistsG-protein coupled receptor modulatorsIntracellular signaling peptides and proteins modulators

TargetsG-protein coupled receptorAngiotensin II receptor type 2Intracellular signaling peptides and proteins

Therapy Area/IndicationsFibrosisDiabetic Nephropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMorphosys Ag

China Registration ClassN/A

Develop Information

Active CompaniesMorphosys Ag

Inactive CompaniesAlan Richardson

Active IndicationsFibrosisDiabetic Nephropathies

Inactive IndicationsN/A

Other Information

ATC CodeN/A